Search for the latest updates on diabetes
News
POXEL Announces Successful Results for Imeglimin Phase 1 Study in Japanese Subjects and Appoints Dr. Yohjiro Itoh to ... Business Wire via Yahoo! Finance - 41 minutes
LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext:POXEL), a biopharmaceutical company developing innovative drugs to treat type 2 diabetes, ...
Manage alerts · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Search. |
No comments:
Post a Comment